Attached Files:

Array ( [icon] => [view_count] => 62 [download_count] => 11 [link_label] => Download [version] => [quota] => [access] => Array ( [0] => guest ) [package_size] => 4.00 KB [publish_date] => [expire_date] => [avail_date_ts] => [avail_date] => [expire_date_ts] => [download_limit_per_user] => [ID] => 274 [post_author] => 3154 [post_date] => 2016-10-03 07:59:30 [post_date_gmt] => 2016-10-03 13:59:30 [post_content] =>

Pharmaceutical Law Vol. II

  For ASIPI it is a great pride to be able to present to you this work that brings together the scientific and legal knowledge of prominent professionals and experts in pharmaceutical or regulatory law in Latin America. In each of its six chapters the authors analyze various problems with great depth, so we do not doubt that it will become a permanent reference document for all of us who work with and value intellectual property. It is emphasized that these studies are published at a time full of challenges for pharmaceutical law in Latin America, so the intention of ASIPI with the publication of this work is to contribute to a debate informed.  

Chapter Fourth Compulsory Licenses

• Compulsory License for reasons of public interest: protect cases of extreme urgency or green light to arbitrariness? Roxana Bacalla Izquierdo and Bruno Merchor Valderrama.
• "Ecuadorian Regime of Compulsory Licensing of Drug Patents. Analysis under the current international treaties "José Meythaler and Andrés Rubio.
• "Patents of the pharmaceutical industry and compulsory licenses. Current situation in Colombia "Carlos R. Olarte García and Maritza Sierra Hernández.
• "Some considerations in relation to compulsory licenses. Mexico" Regina Kuchle, Alejandro López-Velarde and Juan Carlos Macouzet.

Chapter Five Protection of test data

• "Patents and Protection of Test Data. Analysis of the situation in the Argentine Republic" Daniel R. Zuccherino.
• "The Legal Nature of the Protection of Pharmaceutical Test Data" Andrés Rincón Uscátegui.
• "Patents of invention. Pharmaceutical patents Protection of Clinical Data and other topics of interest for the pharmaceutical industry in Mexico " Alejandro Luna.
• "Pharmaceutical Products Test Data: Analysis of local legislation and applicable treaties. First cases - Peru " Maritza Reátegui Valdiviezo.

Chapter Sixth Pharmaceutical Brands

• "Strokes and reflections on the pharmaceutical brand" Javier André Murillo Chávez.
• "Cancellation of pharmaceutical brands: designing a prescription for the preservation of the good health of the trademark system" Gustavo M. Rodríguez García.

[post_title] => Pharmaceutical Law Vol. II [post_excerpt] => Pharmaceutical Law Vol. II   For ASIPI it is a great pride to be able to present to you this work that brings together the scientific and legal knowledge of prominent professionals and experts in pharmaceutical or regulatory law in Latin America. In each of its six chapters the authors analyze various problems with great […] [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => derecho-farmaceutico-vol-ii [to_ping] => [pinged] => [post_modified] => 2022-05-31 02:16:58 [post_modified_gmt] => 2022-05-31 02:16:58 [post_content_filtered] => [post_parent] => 0 [guid] => http://asipi.org/?post_type=publicacion&p=922 [menu_order] => 0 [post_type] => wpdmpro [post_mime_type] => [comment_count] => 0 [filter] => raw [post_content_ml] => [:es]

Derecho Farmacéutico Vol. II

  Para ASIPI es un gran orgullo poder presentar a ustedes esta obra que reúne los conocimientos científicos y jurídicos de destacados profesionales y expertos en el derecho farmacéutico o regulatorio en Iberoamérica. En cada uno de sus seis capítulos los autores analizan diversas problemáticas con gran profundidad, por lo que no dudamos que se convertirá en un documento de consulta permanente para todos los que trabajamos y valoramos la propiedad intelectual. Se resalta que estos estudios se publican en un momento lleno de desafíos para el derecho farmacéutico en América Latina, por lo que la intención de ASIPI con la publicación de esta obra es contribuir a que se realice un debate informado.  

Capítulo Cuarto Licencias Obligatorias

• “Licencia Obligatoria por razones de interés público: ¿proteger supuestos de extrema urgencia o luz verde a la arbitrariedad? Roxana Bacalla Izquierdo y Bruno Merchor Valderrama.
• “Régimen Ecuatoriano de Licenciamiento obligatorio de Patentes de Fármacos. Análisis al amparo de los tratados internacionales vigentes” José Meythaler y Andrés Rubio.
• “Patentes de la industria farmacéutica y licencias obligatorias. Situación actual en Colombia” Carlos R. Olarte García y Maritza Sierra Hernández.
• “Algunas consideraciones en relación con las licencias obligatorias. México” Regina Kuchle, Alejandro López-Velarde y Juan Carlos Macouzet.

Capítulo Quinto Protección de datos de prueba

• “Patentes y Protección de Datos de Prueba. Análisis de la situación en la República Argentina” Daniel R. Zuccherino.
• “La Naturaleza Jurídica de la Protección de Datos de Prueba Farmacéuticos” Andrés Rincón Uscátegui.
• “Patentes de invención. Patentes Farmacéuticas. Protección de Datos Clínicos y otros temas de interés para la industria farmacéuticas en México” Alejandro Luna.
• “Datos de Prueba de Productos Farmacéuticos: Análisis de la Legislación local y tratados aplicables. Primeros casos – Perú” Maritza Reátegui Valdiviezo.

Capítulo Sexto Marcas Farmacéuticas

• “Trazos y reflexiones en torno a la marca farmacéutica” Javier André Murillo Chávez.
• “Cancelación de marcas farmacéuticas: diseñando una receta para la preservación de la buena salud del sistema marcario” Gustavo M. Rodríguez García.

 [:en]

Pharmaceutical Law Vol. II

  For ASIPI it is a great pride to be able to present to you this work that brings together the scientific and legal knowledge of prominent professionals and experts in pharmaceutical or regulatory law in Latin America. In each of its six chapters the authors analyze various problems with great depth, so we do not doubt that it will become a permanent reference document for all of us who work with and value intellectual property. It is emphasized that these studies are published at a time full of challenges for pharmaceutical law in Latin America, so the intention of ASIPI with the publication of this work is to contribute to a debate informed.  

Chapter Fourth Compulsory Licenses

• Compulsory License for reasons of public interest: protect cases of extreme urgency or green light to arbitrariness? Roxana Bacalla Izquierdo and Bruno Merchor Valderrama.
• "Ecuadorian Regime of Compulsory Licensing of Drug Patents. Analysis under the current international treaties "José Meythaler and Andrés Rubio.
• "Patents of the pharmaceutical industry and compulsory licenses. Current situation in Colombia "Carlos R. Olarte García and Maritza Sierra Hernández.
• "Some considerations in relation to compulsory licenses. Mexico" Regina Kuchle, Alejandro López-Velarde and Juan Carlos Macouzet.

Chapter Five Protection of test data

• "Patents and Protection of Test Data. Analysis of the situation in the Argentine Republic" Daniel R. Zuccherino.
• "The Legal Nature of the Protection of Pharmaceutical Test Data" Andrés Rincón Uscátegui.
• "Patents of invention. Pharmaceutical patents Protection of Clinical Data and other topics of interest for the pharmaceutical industry in Mexico " Alejandro Luna.
• "Pharmaceutical Products Test Data: Analysis of local legislation and applicable treaties. First cases - Peru " Maritza Reátegui Valdiviezo.

Chapter Sixth Pharmaceutical Brands

• "Strokes and reflections on the pharmaceutical brand" Javier André Murillo Chávez.
• "Cancellation of pharmaceutical brands: designing a prescription for the preservation of the good health of the trademark system" Gustavo M. Rodríguez García.

[:pb]

Derecho Farmacéutico Vol. II

Capítulo Cuarto Licencias Obligatorias

• “Licencia Obligatoria por razones de interés público: ¿proteger supuestos de extrema urgencia o luz verde a la arbitrariedad? Roxana Bacalla Izquierdo y Bruno Merchor Valderrama.
• “Régimen Ecuatoriano de Licenciamiento obligatorio de Patentes de Fármacos. Análisis al amparo de los tratados internacionales vigentes” José Meythaler y Andrés Rubio.
• “Patentes de la industria farmacéutica y licencias obligatorias. Situación actual en Colombia” Carlos R. Olarte García y Maritza Sierra Hernández.
• “Algunas consideraciones en relación con las licencias obligatorias. México” Regina Kuchle, Alejandro López-Velarde y Juan Carlos Macouzet.

Capítulo Quinto Protección de datos de prueba

• “Patentes y Protección de Datos de Prueba. Análisis de la situación en la República Argentina” Daniel R. Zuccherino.
• “La Naturaleza Jurídica de la Protección de Datos de Prueba Farmacéuticos” Andrés Rincón Uscátegui.
• “Patentes de invención. Patentes Farmacéuticas. Protección de Datos Clínicos y otros temas de interés para la industria farmacéuticas en México” Alejandro Luna.
• “Datos de Prueba de Productos Farmacéuticos: Análisis de la Legislación local y tratados aplicables. Primeros casos – Perú” Maritza Reátegui Valdiviezo.

Capítulo Sexto Marcas Farmacéuticas

• “Trazos y reflexiones en torno a la marca farmacéutica” Javier André Murillo Chávez.
• “Cancelación de marcas farmacéuticas: diseñando una receta para la preservación de la buena salud del sistema marcario” Gustavo M. Rodríguez García.

[:] [post_content_langs] => Array ( [es] => 1 [en] => 1 [pb] => 1 ) [post_title_ml] => [:es]Derecho Farmacéutico Vol. II[:en]Pharmaceutical Law Vol. II[:] [post_title_langs] => Array ( [es] => 1 [en] => 1 ) [title] => Pharmaceutical Law Vol. II [description] =>

Pharmaceutical Law Vol. II

 

For ASIPI it is a great pride to be able to present to you this work that brings together the scientific and legal knowledge of prominent professionals and experts in pharmaceutical or regulatory law in Latin America.
In each of its six chapters the authors analyze various problems with great depth, so we do not doubt that it will become a permanent reference document for all of us who work with and value intellectual property.
It is emphasized that these studies are published at a time full of challenges for pharmaceutical law in Latin America, so the intention of
ASIPI with the publication of this work is to contribute to a debate informed.

 

Chapter Fourth Compulsory Licenses

• Compulsory License for reasons of public interest: protect cases of extreme urgency or green light to arbitrariness? Roxana Bacalla Izquierdo and Bruno Merchor Valderrama.
• "Ecuadorian Regime of Compulsory Licensing of Drug Patents. Analysis under the current international treaties "José Meythaler and Andrés Rubio.
• "Patents of the pharmaceutical industry and compulsory licenses. Current situation in Colombia "Carlos R. Olarte García and Maritza Sierra Hernández.
• "Some considerations in relation to compulsory licenses. Mexico" Regina Kuchle, Alejandro López-Velarde and Juan Carlos Macouzet.

Chapter Five Protection of test data

• "Patents and Protection of Test Data. Analysis of the situation in the Argentine Republic" Daniel R. Zuccherino.
• "The Legal Nature of the Protection of Pharmaceutical Test Data" Andrés Rincón Uscátegui.
• "Patents of invention. Pharmaceutical patents Protection of Clinical Data and other topics of interest for the pharmaceutical industry in Mexico " Alejandro Luna.
• "Pharmaceutical Products Test Data: Analysis of local legislation and applicable treaties. First cases - Peru " Maritza Reátegui Valdiviezo.

Chapter Sixth Pharmaceutical Brands

• "Strokes and reflections on the pharmaceutical brand" Javier André Murillo Chávez.
• "Cancellation of pharmaceutical brands: designing a prescription for the preservation of the good health of the trademark system" Gustavo M. Rodríguez García.

[excerpt] => [thumb] => [preview] => https://staging.asipi.org/biblioteca/wp-content/uploads/sites/14/2016/10/DerechosFarmaII.jpg [preview_alt] => [preview_title] => DerechosFarmaII [featured_image] => [author_name] => editor ASIPI [author_profile_url] => https://staging.asipi.org/biblioteca/en/author/editorasipi/ [avatar_url] => https://asipi.org/biblioteca/wp-content/uploads/sites/14/2019/11/AF-Asipi-Logo-SinLeyenda.jpg [avatar] => [create_date] => Monday October 3rd, 2016 [update_date] => 31 May, 2022 [files] => Array ( [1543266849863] => Derechos-Farmacéuticos-ASIPI-Vol2.pdf ) [file_count] => 1 [file_list] => [play_list] => [audio_player] => [page_url] => https://staging.asipi.org/biblioteca/en/download/derecho-farmaceutico-vol-ii/ [page_link] => Pharmaceutical Law Vol. II [page_url_qr] => [btnclass] => btn btn-primary [tags] => [file_size] => 4.00 KB [download_url] => https://staging.asipi.org/biblioteca/en/download/derecho-farmaceutico-vol-ii/?wpdmdl=274&refresh=6a239f949903c1780719508 [download_link] => Download [download_link_extended] => Download [download_link_popup] => Download [formatted] => 1 [__template] => [__template_type] => page [popover_preview] => [wpcf-tipo] => Libro ) Array ( [0] => ) -----------------

---